Hokkaido University Hospital

Sapporo, Hokkaido 060-8648 060-8648

0 studies enrolling now · 1 studies all time

What they study most

Antiphospholipid (aPL)-Positive

Studies at this site

• Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome — Stopped early